Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03019328 · ClinicalTrials.gov registry record
Early Peanut Introduction: Translation to Clinical Practice
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 333
- Enrollment target
NCT03019328: Completed study, sponsored by Johns Hopkins University.
NCT03019328 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 333 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03019328 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 333 participants
- Enrollment target
Study Summary
The recent finding that early introduction of peanut can prevent \~70-90% of peanut allergy is a major step towards prevention of food allergy. However, because that finding was from a clinical trial in a very select population, there are several major questions that must be answered in order to implement these findings into clinical practice without causing more harm than good. These questions include who, if anyone, should be screened prior to early introduction for peanut allergy, how this screening should be done, and what quantity of peanut ingestion is needed to prevent peanut allergy. The goal of this project is to answer these critical questions so that the potential of these recent findings can be realized. To that end, 400 infants at high-risk of peanut allergy will be enrolled. These infants will be given a peanut skin prick test, peanut food challenge and have blood drawn for measurement of peanut IgE, and then will be followed for assessment of peanut consumption and development of peanut allergy until 3 years of age.
Interventions
- OTHER Peanut in diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2016-12 |
| Est. Completion | 2023-03-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03019328
The ClinicalTrials.gov registry entry for NCT03019328 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut in diet is the first listed.
NCT03019328 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03019328 about?
NCT03019328 is a clinical study titled "Early Peanut Introduction: Translation to Clinical Practice". The recent finding that early introduction of peanut can prevent \~70-90% of peanut allergy is a major step towards prevention of food allergy. However, because that finding was from a clinical trial in a very select population, there are several major questions that must be answered in order to imp...
What is the current status of trial NCT03019328?
This trial is currently completed. The enrollment target is 333 participants. The study started on 2016-12. Estimated completion is 2023-03-24.
What interventions are being tested in trial NCT03019328?
The interventions under investigation include: Peanut in diet (OTHER).
Who is sponsoring clinical trial NCT03019328?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.